Skip to content

SAMABRIVA BIOMANUFACTURING

Dissolution or liquidation
Public limited companyfounded 2023Avenue Pré-Aily 14, 4031 Liège, BelgiumKBO/BCE: BE 1002.863.501

The KBO register records for SAMABRIVA BIOMANUFACTURING the legal situation: dissolution or liquidation; this is today's state according to the register itself, which carries no start date. Dissolved on 13-08-2026, in liquidation; liquidator: GUILLET Marina.

Summary

The 2025 annual accounts show negative equity (-€933,529) and a net result of -€721,999.

SAMABRIVA BIOMANUFACTURINGDissolution or liquidation

Overview

Activity
Wholesale of pharmaceutical and medical goods
NACE 46460
1 site
Size
€1.1mtotal assets 2025
Staff
1.5 FTE
Equity
-€933,529
Loss
-€721,999
Financial health
Dissolution or liquidation: no score
Structure
Parent
SAMABRIVA France · 100%
2 of 4 deeds read
Signals- Negative equity- Young company- Register: dissolution or liquidationLatest accounts filed on timeShow the evidence

Signals

Four signals.
+raises risk○neutral
raises risk · Negative equity
The 2025 annual accounts show negative equity and a net loss.
NBB · annual accounts 2025
Equity per financial year
2425
2024 to 2025 · latest year -€933,529
raises risk · Young company
Founded in 2023, under 3 years in business. Failure risk is statistically highest between 2 and 8 years after founding.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 2 years 0 10 y
raises risk · Register: dissolution or liquidation
The KBO register records the legal situation: dissolution or liquidation. This is today's state according to the register itself; the register carries no start date.
KBO · legal situation
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 08-06-2026, 53 days ahead of the deadline.
NBB · 2 filings
Deviation from the deadline
2025
53 days early
2024
66 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 2 accounts on average 60 days before the deadline; the sector median for financial year 2024 is 3 days before the deadline, and 39% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
08-10-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Checked from 2021 on.
KBO publications · our coverage
  1. Resignations & appointments · End &…Appointment: GUILLET Marina (liquidator) ·…
  2. Annual accounts filedfiscal year 2025 · full…
  3. Appointment: JUSTBEGEST (daily management delegate)Permanent representative: Bertrand Duquesne ·…

Key points

  • Risk: No longer activefounded 30-11-2023 Dissolution or liquidation View
  • Caution: Equity fell in 2025from -€329,806 to -€933,529 ▼ 183% View
  • Controlled by SAMABRIVA Franceknown shareholders 100% 100% View

By topic

Financials

Fiscal year
2025
Total assets
€1.1m
Loss
-€721,999
Solvency
-86.3%
Total assets▼ 53.0%
Net result
20242025
Go to Financials

Company details

Sites
1
Legal form
Public limited company
Activity
Wholesale of pharmaceutical and medical goodsNACE 46460
Founded
30-11-2023
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Investigating this company? Keep it with today's facts in a case file.